Krystal Biotech Inc (KRYS) operating margin is 46.1%
Krystal Biotech Inc (KRYS) operating margin is 46.1% as of 2024-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full KRYS research page for quote, filings, and the rest of the model. This satellite exists so “Krystal Biotech Inc operating margin” can rank with the actual number, then send you to /stock/krys.